Drug details:
Molecular formula: C₂₅H₂₄N₈

Standard name: 6-N-[2-[(4-amino-2-methylquinolin-6-yl)amino]-6-methylpyrimidin-4-yl]-2-methylquinoline-4,6-diamine

Synonym:

6-N-[2-[(4-amino-2-methylquinolin-6-yl)amino]-6-methylpyrimidin-4-yl]-2-methylquinoline-4,6-diamine

Curated SMILES: CC1=CC(NC2=CC=C3N=C(C)C=C(N)C3=C2)=NC(NC2=CC=C3N=C(C)C=C(N)C3=C2)=N1

Evidence for compound's anti-virulence activity:

Salmonella
Related VF: TTSS (SPI-1 encode)
Target: Not determined
Drug effect: Decreases secretion of T3SS proteins.
Max phase: Preclinical (in vitro)
Publication:
von Ambüren J, et al., 2020. Comprehensive Host Cell-Based Screening Assays for Identification of Anti-Virulence Drugs Targeting Pseudomonas aeruginosa and Salmonella Typhimurium. Microorganisms 8(8):1096.